1. Home
  2. DAIO vs RLYB Comparison

DAIO vs RLYB Comparison

Compare DAIO & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Data I/O Corporation

DAIO

Data I/O Corporation

N/A

Current Price

$3.06

Market Cap

23.4M

Sector

Industrials

ML Signal

N/A

Logo Rallybio Corporation

RLYB

Rallybio Corporation

HOLD

Current Price

$0.77

Market Cap

24.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAIO
RLYB
Founded
1969
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.4M
24.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
DAIO
RLYB
Price
$3.06
$0.77
Analyst Decision
Strong Buy
Hold
Analyst Count
1
2
Target Price
$5.22
N/A
AVG Volume (30 Days)
26.6K
177.2K
Earning Date
10-30-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$22,701,000.00
$674,000.00
Revenue This Year
$9.14
$17.61
Revenue Next Year
$2.34
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.71
52 Week Low
$1.88
$0.22
52 Week High
$3.57
$1.20

Technical Indicators

Market Signals
Indicator
DAIO
RLYB
Relative Strength Index (RSI) 56.66 67.98
Support Level $2.86 $0.72
Resistance Level $3.20 $0.80
Average True Range (ATR) 0.14 0.04
MACD 0.05 0.01
Stochastic Oscillator 74.56 84.86

Price Performance

Historical Comparison
DAIO
RLYB

About DAIO Data I/O Corporation

Data I/O Corp is a provider of programming, security deployment, security provisioning, and associated Intellectual Property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices, and secure microcontrollers. It is engaged in focused on the design, manufacturing and sale of programming systems used by designers and manufacturers of electronic products. It has its geographic presence in the United States, Europe, and Asia and others. The company derives the majority of its revenue from Asia and others.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Share on Social Networks: